Cosentyx meets Phase III goals in axial spondyloarthritis patients

During the study, participants received a subcutaneous injection of Cosentyx or placebo. Credit: Hyttalo Souza on Unsplash.



  • Cosentyx meets Phase III goals in axial spondyloarthritis patients